Fresenius Medical Care AG & Co KGaA ST buy Vip1959
Start price
17.08.17
/
50%
€79.50
Target price
15.09.17
€81.75
Performance (%)
2.84%
End price
15.09.17
€81.76
Summary
This prediction ended on 15.09.17 with a price of €81.76. The BUY prediction by Vip1959 finished with a performance of 2.84%. Vip1959 has 50% into this predictionFresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ST | 2.725% | 2.725% | -20.076% | -45.552% |
| iShares Core DAX® | 0.039% | 0.567% | 12.281% | 14.748% |
| iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% | 36.769% |
| iShares Nikkei 225® | -2.389% | -1.434% | 8.335% | 5.073% |
| iShares S&P 500 | -2.115% | -2.351% | 22.061% | 37.971% |
Comments by Vip1959 for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
Vip1959 stimmt der Buy-Einschätzung von papaver zu
Vip1959 stimmt am 17.08.2017 der Buy-Einschätzung von papaver mit dem Kursziel 82€ zu.Überschrift: FMC kauft NxStage